SIMAP500: A novel risk score to identify recipients at higher risk of hepatocellular carcinoma recurrence following liver transplantation

doi:10.5500/wjt.v14.i3.95849

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1305)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

HTML

701

Figures (1-2)

159

Tables (1-6)

152

Sum=1054

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

126

Sum=196

Sep 18, 2024 (publication date) through Jan 5, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Transplant. Sep 18, 2024; 14(3): 95849
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95849

Table 1 Pretransplant donor and tumour characteristics

	No. (%)
Donor age (/years)
Median (Min.-Max.)	54 (12-83)
Donor sex
Male	146 (62.4)
Female	88 (37.6)
Donor type
DBD	126 (53.8)
DCD	108 (46.2)
Tumour largest size (cm)
≤ 5	226 (98.3)
> 5	4 (1.7)
Median (range)	2.4 (1-6.7)
Number of tumours
≤ 3	225 (97)
> 3	7 (3)
Median	1 (1-6)
AFP-listing
< 100	205 (88.8)
100-500	21 (9)
500-1000	1 (0.4)
> 1000	4 (1.7)
Median (range)	7 (1-2634)
TACE	93 (39.7)
Ablation	57 (24.4)
MELD
Median (range)	9 (4-24)
UKELD
Median (range)	49 (41-65)

AFP: Alpha fetoprotein; DCD: Donation after circulatory death; DBD: Donation after brain stem death; TACE: Transarterial chemoembolization; MELD: Model for End-Stage Liver Disease; UKELD: United Kingdom Model for End-Stage Liver Disease.

Citation: Alnagar A, Zakeri N, Koilias K, Faulkes RE, Brown R, Cain O, Perera MTPR, Roberts KJ, Sanabria-Mateos R, Bartlett DC, Ma YT, Sivakumar S, Shetty S, Shah T, Dasari BVM. SIMAP500: A novel risk score to identify recipients at higher risk of hepatocellular carcinoma recurrence following liver transplantation. World J Transplant 2024; 14(3): 95849
URL: https://www.wjgnet.com/2220-3230/full/v14/i3/95849.htm
DOI: https://dx.doi.org/10.5500/wjt.v14.i3.95849